Search filters

List of works by Anna Yordanova

68Ga-PSMA-11 PET Represents the Tumoricidal Effect of 223Ra in a Patient With Castrate-Resistant Metastatic Prostate Cancer

scientific article published on 9 July 2016

68Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223Ra: Proof of Concept.

scientific article

A Step-by-Step Clinical Approach for the Management of Neuroendocrine Tumours.

scientific article published on 18 January 2017

Advances in Molecular Imaging and Radionuclide Therapy of Neuroendocrine Tumors

scientific article published on 16 November 2020

Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer

scientific article

Diagnostic accuracy of [99mTc]Tc-Sestamibi in the assessment of thyroid nodules.

scientific article published on 17 October 2017

Outcome and safety of rechallenge [177Lu]Lu-PSMA-617 in patients with metastatic prostate cancer

scientific article published on 24 November 2018

Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617.

scientific article published on 9 May 2017

PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.

scientific article published on 12 October 2017

Peptide Receptor Radionuclide Therapy Combined With Chemotherapy in Patients With Neuroendocrine Tumors

scientific article published on 01 May 2019

Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617.

scientific article published on September 2016

Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy.

scientific article published on 7 October 2017

Radioligand therapy of metastatic prostate cancer using 177Lu-PSMA-617 after radiation exposure to 223Ra-dichloride.

scientific article

Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis.

scientific article

Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour.

scientific article

Successful Repeated Peptide Receptor Radionuclide Therapies in Renal Neuroendocrine Tumor With Osseous Metastasis.

scientific article published on 5 October 2016

The Role of Adding Somatostatin Analogues to Peptide Receptor Radionuclide Therapy as a Combination and Maintenance Therapy

scientific article published on 27 June 2018

The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.

scientific article published on 23 March 2017

The value of tumor markers in men with metastatic prostate cancer undergoing [177 Lu]Lu-PSMA therapy

scientific article published on 03 October 2019

Theranostics in nuclear medicine practice

scientific article published on 3 October 2017

Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer.

scientific article

[18F]Fluorodeoxyglucose Positron Emission Tomography Reveals a Complete Remission of Refractory Metastatic Melanoma after Therapy with Ipilimumab.

scientific article

Paulina is supported by:

About Paulina

Help